MDC Connects 2024: Webinar 5/5

Intelligent OMICS

Public and private transcriptomic data sets analysed by a suite of AI tools:

Intellomx Distiller

Identification of key genes

Intellomx Driver

Identification of key disease drivers

Intellomx Miner

Defining the disease pathway

Intellomx Digital Twin Anticipate Tox Liabilities

Value Proposition:

Deploying AI and ML to extract biological knowledge from OMICS data

Identifying causal drivers of disease and expediting the biomarker and drug discovery processes.

Business Model:

1. Technology Driven Consultancy Service model

2. Downstream Drug Discovery Value

3. Generate IP of value by exploiting biological knowledge - Licensing

Intellomx Precise Panel optimization for diagnostics

Be driven by the problem…

Position any innovation in the context of an existing well understood industry challenge:

• Therapeutic Class e.g. Oncology, Fibrotic Disease, Neuroscience

• Platform Need e.g ADCs, Protein-protein interactions

• Development Bottle Neck e.g. Patient recruitment technologies, Advanced therapies manufacturing

Confirm these challenges through customer discovery

Articulate your solution in the context of problem…

Problem: Drug Development is rife with expense and time consuming failure.

Solution: Intellomx allows partners to better understand disease biology without the bias of previous literature and select causal, stable targets present across a disease population.

The commercialization conundrum…

• Intellomx has the ability to provide a service and generate IP

• Long term value vs short term viability

• Solution….do both strategically

• Near term revenue generating fee for service

• Long term value generation through collaborative research

Route to Market

• Marketing channels & strategy

• Who is the buyer

• BD or sales?

• Recurring service or one-off deal?

• Licensing model?

Working with J&J…

Deal source: Email Circular and InPart

• Integration into biology and data science teams

• Exposure to wider R&D organisation

• JLABS membership

• CEO roundtables

• Community membership

• Industry validation

Causal disease modelling of Sjogren’s Disease

Working with Servier

Deal Source: Email Circular

• Integration into biology and data science teams

• Exposure to wider R&D organisation –subsequent project extension into Neuroscience TA

• Refinement of methodology

• Publication submission

Learnings…

• Speak to a clear problem

• Identify a champion with need and budget

• Build upon relationships to extend commercial partnerships

• DELIVER!